메뉴 건너뛰기

추천
검색
질문

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
이 논문의 연구방법이 궁금하신가요?
🏆
연구결과
이 논문의 연구결과가 궁금하신가요?
AI에게 요청하기
추천
검색
질문

초록· 키워드

The effects of IH901, a ginseng intestinal metabolite, on the antitumor activity and cardiotoxic adverse effect of doxorubicin were investigated in sarcoma-180 ascitic tumor-bearing mice. To evaluate the enhancing effect on the antitumor activity of doxorubicin, IH901 (50 ㎎/㎏) was orally administered for 28 days, in combination with intraperitoneal injection of doxorubicin (3 ㎎/㎏) on days 5, 12, 19 and 24, to mice intraperitoneally inoculated with 1 × 10? sarcoma-180 cells. The body weights of tumor-bearing mice dramatically increased from 10 days following tumor inoculation, leading to a mean survival time of 17.3 days. In contrast, such an increase in body weights induced by the ascitic tumor growth was markedly attenuated by doxorubicin (3 ㎎/㎏) administration, resulting in a long lifespan of 34.9 days. Interestingly, the body weight gain was further suppressed by the combination of IH901 (50 ㎎/㎏), leading to a normal feature. In addition, the mean survival time was extended by 129.3%, reaching 39.7 days, although IH901 was inactive alone. Separately, for the evaluation of protective effect on the cardiotoxicity of doxorubicin, IH901 (50 ㎎/㎏) was orally administered for 14 days, in combination with intraperitoneal injection of doxorubicin (5 ㎎/㎏) on days 5 and 9 to tumor-bearing mice. Although the heart weight of tumor-inoculated mice decreased to about 75% of normal, such an atrophy was remarkably recovered by coadministration of IH901. Furthermore, IH901 substantially reversed the dramatic decrease in mRNA of myocytic phospholipid hydroperoxide glutathione peroxidase, an antioxidant enzyme, as well as histopathological changes such as cytoplasmic vacuolization, mitochondrial swelling, and loss of myofibrils and intercalated disc induced by doxorubicin. Taken together, it is suggested that IH901 could be a potential adjunct for the potentiation of antitumor activity and reduction of cardiotoxicity of chemotherapeutic agents including doxorubicin.
상세정보 수정요청해당 페이지 내 제목·저자·목차·페이지
정보가 잘못된 경우 알려주세요!

목차

  1. Introduction
  2. Materials and Methods
  3. Results
  4. Discussion
  5. Acknowledgment
  6. References

참고문헌

참고문헌 신청

최근 본 자료

전체보기
UCI(KEPA) : I410-ECN-0101-2009-510-016362156